An Italian environmental study shows that air pollution increases the risk of autoimmune diseases, in particular rheumatoid arthritis, connective tissue diseases (CTDs) and inflammatory bowel diseases (IBD).
Previously environmental pollutants have been linked to an increased risk of RA onset and also, flares of RA or lupus.
Dr. John Cush RheumNow
4 years 6 months ago
Who's to Blame?
A Patient with Psoriatic Arthritis Dies from Sepsis - what was the cause of sepsis and death?
QD Clinic is sponsored by https://t.co/4UQlqwujiR (March 19 & 20, 2022 in Las Colinas, Texas)
https://t.co/lUfQHpNIOc https://t.co/HHk4hFs5ZS
Dr. John Cush RheumNow
4 years 6 months ago
Efficacy and Safety of Mavrilimumab in Giant Cell Arteritis
A phase II trial in patients with active giant cell arteritis shows that mavrilimumab, a monoclonal antibody against GM-CSF is capable of inducing clinical remission.
https://t.co/QmACP1ESFG https://t.co/EeWxTZuFbw
Dr. John Cush RheumNow
4 years 6 months ago
Doctors in the Dark
The modern way to real-time consult with specialists
QD Clinic is sponsored by https://t.co/4UQlqwujiR (March 19 & 20, 2022 in Las Colinas, Texas)
https://t.co/rd5blbrORD https://t.co/O5X64tKNmh
Dr. John Cush RheumNow
4 years 6 months ago
Predicting Spondylitis in At-Risk Relatives
The risk of developing axSpA if you’re a first-degree relative (FDRs) of an AS patient has been defined by a 35 year follow-up study showing that if you are a FDR of axSpA you may be at higher risk of AAU.
https://t.co/wezFZUhyZZ https://t.co/VASbJZt9UV
Dr. John Cush RheumNow
4 years 6 months ago
Join us on Saturday either in-person or virtually!
https://t.co/GY4ZPderis
https://t.co/OIo5QHBqEF
Dr. John Cush RheumNow
4 years 6 months ago
Study of 1141 consecutive gouty pts finds 10 (0.9%) with "Shrinking Toes" in those w/ tophaceous gout (usually MTP1,2) - toe shortening mainly due to lytic bone collapse during articular tophus dissolution (esp in severe gout w/ severe erosions) https://t.co/fiwhiDKKgf https://t.co/C22GpGiA1l
Dr. John Cush RheumNow
4 years 6 months ago
In a Belgian cohort study of 2492 RA pts, 697 Rx w/ a TNF inhibitor -- four developed TNFi (3ETN, 1INFLX) induced sarcoidosis. 2 w/ pulm sarcoid and hilar LN; 1 Heerfordt synd; 1 w/ granulomas and ^^calcium. All recoved w/ steroids and TNFi-DC https://t.co/qvUND1WER4 https://t.co/wxN2SYjcIn
Whether patients with ankylosing spondylitis (AS) would improve substantially with tumor necrosis factor (TNF) inhibitor therapy was predicted with moderate to high accuracy based only on a standard lab test and two measures of disease activity, researchers reported from a modeling study.
A novel biologic intervention trial has shown that subcutaneous, intermittent therapy with low-dose interleukin-2 (Ld-IL2) is potentially effective and safe in rheumatoid arthritis (RA).
Eric Topol EricTopol
4 years 6 months ago
What happens in the UK and Europe doesn't stay there.
5 out of 5 warnings predicted what would happen in this US.
Let's make believe the 6th won't. https://t.co/BFPpGsZXV7
Janet Pope Janetbirdope
4 years 6 months ago
#ClinicalPearl Thickened R Achilles’ tendon, dry flakey skin, dystrophic toe nails = .....? https://t.co/ERVYkeJuuA
Dr. John Cush RheumNow
4 years 6 months ago
Join Dr. Pamela Weiss, this weekend at RheumNow Live where she will present and discuss Juvenile Spondyloarthritis.
Full the full agenda, and to register, head to https://t.co/2dcFVgu8z6 https://t.co/WLDVXy7bYT
Dr. John Cush RheumNow
4 years 6 months ago
UK study of 4·16 million adults/children, shows incidence of Alopecia Areata (AA) to be 0·26/ 1000 person-yrs. AA point prevalence 0·58% in 2018, peaked ages 25–29 years, more likely in nonwhites, those w/ social deprivation & urban living https://t.co/RzuBLt5pmS https://t.co/mmwS9nRfbN
